In RA models, IL-17A is implicated in disease pathogenesis, but clinical trials targeting IL-17A alone yielded modest effects, suggesting that other IL-17 family members, such as IL-17F, may also be involved (47). Here, IL17A is linked to rheumatoid arthritis.